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 Many psychotic patients fail to admit they are mentally ill.  The current study 
evaluated the associations between insight, specific symptoms, and neurocognitive 
impairments.  Thirty-three acute inpatients with a schizophrenia, schizoaffective disorder, 
or psychotic disorder NOS diagnosis were rated on the SAIE, Birchwood's IS, and the 
BPRS.  Neurocognitive assessments of attention and frontal lobe functioning were also 
conducted.  Stepwise multiple regression analyses found composites representing 
delusions, disorganization, and anxiety/depression, as well as CPT-IP shapes hit rate, 
served as significant predictors of total insight or the specific insight dimensions.  At 
least for acute patients, symptoms tended to have stronger relationships with and were 
more regularly predictive of insight than neurocognitive measures, though the attentional 
task associated with right hemisphere functioning, contributed significantly. 
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Until the last decade, insight into illness has received little systematic examination
(Collins, Remington, Coulter, & Birkett, 1997; David, 1990).  Hypotheses about the
causes for poor insight range from an understanding that it is a psychological defense
mechanism to theoretical positions implicating cognitive deficits with many varied
constructs in between (Amador, Strauss, Yale, & Gorman, 1991).  The concept of insight
most relevant to mental health professionals often involves how an individual’s
perception of self may be grossly different from that of his or her community and culture
(Amador & Kronengold, 1998).  However, researchers have come to view and define
insight as a continuous and multidimensional construct (Amador et al., 1993, 1994;
Amador & David, 1998; David, 1990; McEvoy et al., 1989a).  Important dimensions of
insight include not only the awareness or recognition of having (or having had) a mental
illness, but also the realization of need for treatment, ability to re-label unusual mental
events as pathological, and ability to attribute appropriate causes for mental illness
(Amador & Kronengold, 1998; David, 1998).  Also, insight is not currently viewed as
something that is present or absent, but varies continuously on each dimension.
Research findings that impaired awareness can be limited to specific dimensions
and that percentage of improvement from baseline can vary across dimensions has lent
support to this multidimensional approach (Amador et al., 1994; Kemp, Hayward, &
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David, 1996).  In addition, factor analytic research suggests that insight is an independent
feature of psychotic disorders rather than merely a secondary manifestation of psychotic
symptomatology (David et al., 1992; Peralta & Cuesta, 1994).
Lack of insight is a distinctive feature of severe psychotic disorders (Amador &
David, 1998; Carpenter et al., 1979; Lewis et al., 1934). Over half of all psychotic
inpatients, particularly those with schizophrenia, fail to acknowledge their mental illness
(Amador et al., 1994; Kemp & David, 1996; Lysaker, Bell, Bryson, & Kaplan, 1998;
McEvoy, Schooler, Friedman, Steingard, & Allen, 1993a; Neumann, Walker, Weinstein,
& Cutshaw, 1996; Walker & Rossitor, 1989; Young et al., 1998).  Slightly higher rates of
insight have been reported in outpatients, though it should be noted participants in these
studies were recruited from psychoeducational programs (Dickerson, Boronow, Ringel,
& Parente, 1997; McEvoy, Freter, Merritt, and Apperson, 1993b).
As part of the DSM-IV field trials, Amador et al., (1994) found that nearly 60% of
the patients with schizophrenia evidenced moderate to severe unawareness of having a
mental disorder. Though patients with schizophrenia produced the poorest insight scores,
average awareness scores were not significantly different between patients with
schizophrenia, schizoaffective, and bipolar disorder.  In a review, Ghaemi (1997)
concluded that poor insight appears to be a prominent characteristic in bipolar disorder,
with lack of insight as prominent in mania as it is in schizophrenia (though less severe in
depression).  In a study that included patients from four diagnostic groups (including
paranoid schizophrenia), Sanz, Constable, Lopez-Ibor, Kemp, and David (1998)
demonstrated patients with schizoaffective disorder (manic subtype) and bipolar disorder
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(manic subtype) showed least insight.  Thus, it appears that deficits in insight are more
associated with the presence of psychotic symptoms rather than a specific diagnosis.
Since awareness of illness can impact a patient’s clinical picture, investigators
have been attempting to better understand insight and its correlates. In a large study of
recent-onset, mixed psychotic patients, lack of insight had a significant relationship with
time spent in hospital and living independently regardless of the specific psychotic
diagnosis or other prognostic indicators (Van Os et al., 1996).  A positive association
between level of insight and treatment compliance has repeatedly reported in the
literature (Bartko, Herczeg, & Zador, 1988; David, 1998; David, Buchanan, Reed, &
Almeida, 1992; McEvoy, 1998; McEvoy et al., 1989b; Sanz, Constable, Lopez-Ibor,
Kemp, & David, 1998; Van Putten, 1974). A significant correlation has also been found
between insight and contact with mental health services (Sanz et al., 1998).  Additionally
poor insight has been linked to decreased global functioning (Amador et al., 1994) and
lower social class (David et al., 1995), while good insight has been associated with better
vocational rehabilitation (Lysaker and Bell, 1995).  Finally, a measure of social
knowledge developed by Cutting and Murphy (1988, 1990) has been found to be
significantly correlated to insight (McEvoy et al., 1996).
Currently, there are several reliable and valid multidimensional assessments of
insight, which utilize either an interview or self-report format. The interview assessment
method has been most often relied upon. Four of the most widely used include: (a) the
Scale to Assess the Unawareness of Mental Disorder (SUMD; Amador et al., 1993) with
higher scores indicating poorer insight; (b) The Schedule for the Assessment of Insight
(SAI; David, 1990); (c) the Schedule for the Assessment of Insight – Expanded Version
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(SAI-E; Kemp & David, 1997); and (d) the Insight and Treatment Attitudes
Questionnaire (ITAQ; McEvoy et al., 1989).  Higher scores indicate better insight for the
latter assessments.  Two self-report measures have been reported as psychometrically
sound (Birchwood et al., 1994; Markova & Berrios, 1992).  Strauss (1998) has suggested
that research involving both subjective (self-reports) and more objective (interview)
assessment as an area of further research.  Indeed, little research has been conducted
comparing clinician ratings of insight with client self-reports.
While research on insight has resulted in instruments that are fairly well
established, the correlates of insight have yet to be fully and definitively discerned
(Amador & David, 1998).  Two areas of current research concern are the associations
between insight and specific psychotic symptoms and the role of neuropsychological
deficits in awareness of illness.  For instance, Young, Davila, and Scher (1993) found that
a linear combination of WCST perseverative responses and average symptom severity
correctly categorized 84% of two patient groups categorized as high versus low insight.
Such findings suggested further exploration of how neuropsychological functioning and
symptoms were related to the construct of insight.
Of particular importance in the current study was the inclusion of attentional
measures within the neuropsychological battery, since little research has examined the
possible relationship between attention and insight.  Since research has demonstrated
that attentional functioning is related to social functioning in schizophrenia, the current
study examined how social knowledge was related to insight (Addington & Addington,
1998; Freedman, Rock, Roberts, Cornblatt, & Erlenmeyer-Kimling, 1998; Leih-Mak &
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Lee, 1997).  Notably, McEvoy (1996) found social knowledge was associated with
insight.
For the purposes of this study, the terms insight and awareness of illness will be
used interchangeably.  Furthermore, the terms neuropsychological deficits,
neurocognitive deficits, and cognitive deficits will also be used interchangeably.
Symptom Correlates of Insight
Between the late 17th century and early 19th century, lack of insight was viewed as
being synonymous with mental illness and interest in exploring the implications of
varying degrees of insight in the mentally ill would have been viewed as nonsensical
(Berrios & Markova, 1998).  Even into the present century, the widely held belief that
insight and acute psychosis were incompatible has hindered research and assessment of
insight (David, 1990).
However, the view that severe psychopathology is the cause of poor insight or
precludes insight has not been supported (Aga, Agarwal, & Gupta, 1994; Cuesta &
Peralta, 1994; David, Buchanon, Reed, & Almeida, 1992; David et al., 1995; McEvoy et
al., 1996).  David et al., (1992) found a correlation of r = -.31 between the Present State
Examination (PSE; Wing, Cooper, & Sartorius, 1974) total score and the Schedule for
Assessing Insight (SAI; David, 1990) total score.  Comparing the Brief Psychiatric
Rating Scale (BPRS; Overall & Gorham, 1962) total score with the SAI total score, Aga
et al., (1994) found a correlation of r = .28. McEvoy et al., (1996) did not find a
significant correlation between BPRS total score and insight. Cuesta and Peralta, (1994)
demonstrated that insight was not correlated with either the total score for the Scale for
the Assessment of Negative Symptoms (SANS; Andreason, 1984a) or the total score for
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the Scale for the Assessment of Positive Symptoms (SAPS; Andreasen, 1984b).  Finally,
David et al., (1995) determined that the mean PSE total score was not correlated with the
PSE insight item.  The sum of these findings suggest that insight is largely independent of
global severity of psychopathology (David, 1998).  As such, investigators have focused
on more specific symptom dimensions.
Psychotic symptoms and insight.  Interest has been focused on the relationship
between insight and the positive symptoms of schizophrenia.  Positive symptoms are
phenomenon that are present in individuals with psychotic disorders (e.g., schizophrenia)
that are not present in healthy individuals and include such phenomena as delusions and
hallucinations.  The majority of investigations have found significant, if frequently
moderate, inverse relationships between insight and positive symptoms (Amador et al.,
1994;Collins, Remington, Coulter, & Birkett, 1997; David et al., 1992; Kemp & Lambert,
1995; Markova & Berrios, 1992; Michalakeas et al., 1994;Takai, Uematsu, Hirofumi,
Sone, & Kaiya, 1992; Young, Davila, & Scher, 1993).  Yet some have failed to find such
a relationship (Cuesta & Peralta, 1994) and arguments have been made that any
relationship between the two is spurious (Cuesta & Peralta, 1994; McEvoy et al., 1989b).
Research conducted by McEvoy et al., (1989b) found insight levels remained
constant while positive symptomatology improved and the authors concluded that the
mechanisms responsible for insight and positive symptoms were independent.  In another
study, McEvoy et al. (1989a) found that degree of psychopathology diminished in all
patients with schizophrenia, however, only those who had voluntarily admitted
themselves into treatment had insight ratings that also improved over the course of
hospitalization. It could be argued that those patients who voluntarily admitted
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themselves to the hospital had a greater capacity for insight; for despite hallucinations
and delusions, they came to the conclusion they needed help even if this realization was
expressed in delusional terms (i.e. patient seeks hospitalization so doctors can remove the
short-wave radio from his brain). The findings suggest that positive symptoms may serve
more of a moderating role in expression of insight rather than a determining role in
overall capacity for insight.
There are problems with leaving our understanding of the symptom correlates of
insight at the level of positive symptoms.  First, there is considerable variability in the
number of symptoms included in scales designed to assess positive, as well as negative,
symptoms and there are still symptoms that are inconsistently classified between these
two categories (Walker & Lewine, 1988). Additionally, positive symptoms are too
frequently applied to schizophrenia, and should be applied to other psychotic disorders.
Continued application of positive symptoms only to schizophrenia fails to acknowledge
the association of such symptoms with insight in other psychotic disorders.  Finally,
David (1998) argues that continued attempts to understand the relationship between
insight and different psychotic symptoms will hopefully further our understanding of
both.
Research has indicated that specific symptoms of psychosis are significantly
associated with insight, as opposed to global scores.  For instance, moderate to large
inverse correlations have been found between insight and: delusions (Dickerson et al.,
1997; Neumann, Walker, Weinstein, & Cutshaw, 1996; Sanz et al., 1998), grandiosity
(Kemp & Lambert, 1995; Neumann et al., 1996; Neumann & Walker, 1998; Sanz et al.,
1998; Van Putten, Crumpton, & Yale, 1976), disordered thought (Amador et al., 1994;
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Kim, Sakamoto, Kamo, Sakamura, & Miyaoka, 1997), and disorganized behavior
(Amador et al., 1994).
Interestingly, negative correlations have not been found between hallucinations
and insight.  David et al. (1992) did not find a significant relationship between any
hallucination modality and insight. Nayani and David (1996) found that beliefs that
hallucinations were externally generated did not appear to covary with more broadly
defined insight into illness.  Results of Neumann et al., (1996) suggested that
hallucinatory behavior was related to increased insight, and they proposed that insightful
patients may be better able to recognize and report their aberrant sensory experiences
than non-insightful patients.  In conclusion, research findings suggest that positive
symptoms of delusions, grandiosity, and disordered thought are negatively correlated
with insight. The relationship between hallucinations and insight, if any exits, is not as
clear.  These results suggest that it may be important to study positive symptoms such as
delusions and hallucinations separately, and that not all positive symptoms are
specifically associated with insight.
Affective symptoms and insight.  Another area of interest is the association
between specific affective symptoms and insight.  Several researchers have noted an
inverse relationship between elated mood and insight (Bartko et al., 1988; David, 1990;
Heinrichs, Cohen, & Carpenter, 1986; Kemp & Lambert, 1995; Van Putten et al., 1976).
The link between lack of awareness and elated mood has also been observed in
anosognosia, particularly when lack of awareness reaches a state of denial of afflicted
body parts (David, 1990).  In their research with a psychotic patient population, Sanz et
al. (1998) found those patients with manic subtype distinctions to have the least insight
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overall. Garety (1998) proposed that mania (and delusions) may serve a protective role
in the maintenance of positive affect.
Attempts to determine whether depression is related to better insight have not
resulted in a definitive consensus. However, the majority of studies have found positive
correlations between depression and insight in psychotic patients (Amador et al., 1994;
Carroll et al., 1999; David et al., 1995; Dickerson et al., 1997; Kemp et al., 1995; Peralta
et al., 1994; Michalakeas et al., 1994; Moore et al., 1999; Neumann et al., 1996; Sanz et
al., 1998; Smith et al., 1998; Smith et al., 2000).  A few studies have found inverse
correlations (Collins et al., 1997; Kemp & Lambert, 1995). The difference in findings
may be due, in part, to the fact that the studies which found inverse correlations relied
only on participants with a diagnosis of schizophrenia.
Interest in the relationship between anxiety and insight has only emerged recently,
given that most of the focus has been on positive symptoms, depression, and negative
symptoms (Amador et al., 1994; Collins et al., 1997; Kim et al., 1997). Dickerson,
Boronow, Ringel, and Parente (1997) found symptoms of anxiety were positively
correlated with insight.  Neumann et al., (1996) also found increased anxiety/depression
was related to increased insight; however, further exploration showed that anxiety was
specifically correlated with better insight (r = .52, p<.01).
In discussing the question of whether insight has good prognostic value, David
(1990) argues that coming to an awareness of illness may involve a tragic and painful
struggle against the psychotic disturbance being experienced.  For support he cited the
findings of Roback and Abramowitz (1988) that insightful patients were better
behaviorally adjusted while hospitalized; yet they had higher levels of psychological
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distress.  Taylor and Perkins (1991) also found those patients who denied mental health
problems had higher self-esteem and less subjective distress.  As such, higher levels of
psychological distress found in insightful patients appear to be the result of increased
anxiety and depression.
Negative symptoms and insight.  Associations between negative symptoms and
insight have been noted. Dickerson et al., (1997) found increased emotional withdrawal
was negatively correlated with insight.  Kemp and Lambert (1995) reported poor insight
was associated with increased negative symptoms.  Collins et al., (1997) reported a small,
but significant, inverse correlation between negative symptoms and insight (r = -.38).
However, further analysis of their data via multiple regression indicated that negative
symptoms alone did not contribute to the prediction of insight (Collins et al., 1997).
Other research has failed to find a relationship between negative symptoms and psychotic
patients (Almeida, Howard, Levy, & David, 1996: David, 1998).
Amador and Kronegold (1998) argue that a relationship does exist between
negative symptoms and insight.  They hypothesize that lack of insight results from an
inability to experience emotion, and that this inability to experience emotion arises, at
least in part, from neuropsychological deficits associated with the deficit syndrome.
Cognitive Correlates of Insight
Amador et al. (1991) suggested that at least some forms of poor awareness of
illness could stem from neuropsychological dysfunction. Results of several studies
suggest diminished insight is associated with cognitive impairment (Amador et al., 1991;
Collins et al., 1997; Lysaker, Bell, Milstein, Bryson, & Beam-Goulet, 1994; Lysaker &
Bell, 1998, 1995, 1994; McEvoy et al., 1996; Silverstein & Zerwic, 1985; Walker &
11
Rossiter, 1989; Voruganti et al., 1997; Young et al., 1993; 1998).  Additionally,
researchers have founds relationships between insight and intelligence and/or educational
level (David et al., 1995; Lysaker et al., 1994; Young et al., 1993).
Interest in possible neuropsychological links to poor insight stemmed from its
similarities to the unawareness of illness found in neurological disorders.  In 1914,
Babinski was the first to describe the deficits in insight among patients with neurological
disorders, which he termed anosognosia (as cited in Amador et al., 1991 and David,
1990).  Anosognosia is most commonly observed in individuals suffering with
hemiplegia, paralysis of one side of the body, and hemiopia, blindness in one half of the
visual field, following stroke.  This unawareness of illness can range from indifference to
the affected limbs when they are shown to the afflicted individual to delusional,
quasipsychotic ideas that the affected limb belongs to someone else.  Similar to
schizophrenia, anosognosia is fairly intractable to direct confrontation with irrefutable
proof to the contrary (Amador et al., 1991).
McGlynn and Schacter (1989) report that anosognosia is usually confined to
lesions of the right hemisphere and usually then within the parietal lobe.  Not
surprisingly, the right parietal lobes have also been linked to people’s ability to orient
their attention to stimuli (Deutsch, Papanicolaou, Bourbon, & Eisenberg, 1987).  Despite
the suggestion that damaged attentional centers may play a role in anosognosia and thus
perhaps in insight, limited research has been devoted to this area.  Much more focus has
been placed on researching possible connections between insight and another area
implicated in anosognosia, the frontal lobes (Stuss & Benson, 1986).
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Frontal lobe functioning and insight. Stuss and Benson (1986) proposed that
awareness deficits share an inability to self-monitor or self-correct, and that intact
prefrontal functioning is necessary for self-awareness.  Collins et al. (1997) reported that
functional and structural lesions of the frontal lobes and temporal parietal system have
been implicated in both anosognosia and schizophrenia.  Thus, the majority of research
exploring neurocognitive impairment and insight has focused on how the Wisconsin Card
Sort Test (WCST; Heaton, Baade, & Johnson, 1978) is associated with insight.
Lysaker et al. (1998) studied 81 patients with schizophrenia or schizoaffective
disorder and found performance on the WCST was specifically associated with impaired
insight.  Of interest, the impaired subjects in the study displayed greater positive
symptoms and a later age of first hospitalization (see also Lysaker & Bell, 1998).  Young
et al. (1998) found that deficient insight was significantly associated with worse WCST
and decreased IQ; however, these relationships held only for the participants with
schizophrenia (n=108) and not for the participants with bipolar disorder (n=21).
Additionally, Lysaker and Bell (1994) studied 92 participants with schizophrenia and
found impaired insight was consistently related to poor WCST performance over a period
of one year, even when adjusted for intelligence.  The inverse relationship between
insight and poor performance on the WCST has also been found in other research
(McEvoy et al., 1996; Voruganti et al., 1997; Young et al., 1993).
Other studies have not found a relationship between the WCST and insight
(Collins et al., 1997; Cuesta & Peralta, 1994; Dickerson et al., 1997; McEvoy et al.,
1993b; Sanz et al., 1998). These studies may not have found a significant relationship for
some of the following reasons: (a) small sample size (Cuesta & Peralta, 1994, 1995;
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McEvoy et al., 1993b; Sanz et al., 1998); (b) having a sample of relatively young patients
with a mix of psychotic disorders (Cuesta & Peralta, 1994; Sanz et al., 1998); (c)
restricted range due to lack of variability on the insight variable (Cuesta & Peralta, 1995);
or (d) using a sample of schizophrenic outpatients (Dickerson et al., 1997; McEvoy et al.,
1993).
Clearly, the relationship between insight and the WCST involves a number of
other factors.  For instance, Kemp and David (1996) did not find a relationship between
poor insight and cognitive functioning at hospital admission, but they did find a
correlation between these variables at discharge.  They proposed that the degree of
psychopathology during the acute stages of illness may obscure the relationship between
insight and cognitive functioning.  They have also pointed out that studies that have
found a relationship between insight and cognitive functioning usually draw their results
from participant pools that are older and more chronic than the participants in those
studies with negative results (Kemp & David, 1996).  Similarly, Collins et al. (1997) have
suggested that studies which did not find a link between neuropsychological impairment
and insight involved participants who had a shorter mean duration of illness and appeared
to be less ill when compared to those in the studies which did find a connection.
Amador et al. (1993) reported that, in addition to positive symptoms, increased
age of onset and number of previous hospitalizations was related to poorer insight.
Neumann et al. (1996) found an inverse correlation between age and insight.  Kim et al.
(1997) also found that increased age, as well as increased age at onset, was correlated
with decreased insight (i.e., relabeling).  In sum, the above research suggests that age and
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other clinical factors may have a moderating effect on the relationship between insight
and neuropsychological functioning.
It should be kept in mind that the WCST is a fairly complex test and that the
typical elements of good performance on it have not been fully discerned (Stratta et al.,
1997).  In attempting to gain a better understanding of the cognitive correlates of insight,
it would be beneficial to expand the neuropsychological batteries used and thus explore
possible relationships between other neurocognitive functions and insight.  As mentioned
earlier, there has been little published research that explores the possibility of an
association between insight and attention.
Attention and insight.  Since the beginning of this century, researchers and
scholars have noted a relationship between poor attention and schizophrenia (Kraepelin,
1902).  Extensive research has been conducted exploring deficits in selective attention
and distractibility in schizophrenia (see reviews by Nuechterlein & Dawson, 1984;
Erlenmeyer-Kimling & Cornblatt, 1987).  Attentional deficits or impairments have been
linked to the symptoms of schizophrenia (Braff, 1993; Strauss, Buchanan, & Hale, 1993),
and Perry and Braff (1994) have suggested attentional deficits may in part produce
symptoms of schizophrenia.  Various studies have suggested that both negative
symptoms (Basso, Nasrallah, Olson, & Bornstein, 1998; Ito, Kanno, Mori, & Niwa, 1997;
Roitman, Keefe, Harvey, Siever, & Mohs, 1997) and positive symptoms (Berman et al.,
1997; Green & Walker, 1986) are associated with attentional deficits.
Cornblatt, Obuchowski, Schnur, and O’Brien (1997) have suggested that impaired
attention is an independent feature of schizophrenia, separate from clinical status, and
shows only limited normalization with medication therapy.  In support of this, Cornblatt
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and Erlenmeyer-Kimling (1985) found attentional abnormalities in childhood had high
specificity but only moderate sensitivity as predictors of subsequent schizophrenia.
Additionally, precursor data collected by Neumann, Walker, Lewine, and Baum (1996)
indicated that childhood attentional problems predicted poorer attentional functioning in
adult subjects with schizophrenia. Orzack and Kornetsky (1966, 1971) found attentional
deficits were detectable in remitted patients as well as those in episode and were not a
secondary product of chronicity, illness severity, or length of hospitalization.  Several
studies have found that while medication enhances attention, independent of clinical
improvements, it does not improve attention to normal levels (Earle-Boyer, Serper,
Davidson, & Harvey, 1991; Harvey et al., 1990; Serper, Bergman, & Harvey, 1990).
Finally, Judd-Finkelstein, Cannon, Gur, Gur, and Moberg (1997) found that despite
improvements in psychotic symptoms, patients with schizophrenia displayed poor
attentional functioning both on and off medication.
As stated earlier, insight is a distinctive feature of severe psychotic disorders, not
only schizophrenia. Relatedly, impaired attention has been noted in other psychiatric
patients, and not just in schizophrenia.  For instance, patients with bipolar disorder, both
during acute manic and post manic phases, show impairments in attentional functioning
(Flemming & Green, 1995; Green, Nuechterlein, & Mintz, 1994).  Attention deficits have
been observed in delusional patients (Fear et al., 1996).  Finally, Nelson, Sax, and
Strakowski (1998) found that both schizophrenics and depressed patients with psychotic
features showed worse attention than depressed-only patients and controls.
Some researchers have asserted that attention may be linked to insight. Keefe
(1998) posits that a supervisory attentional system is responsible for individuals ongoing
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awareness of the information they hold, and it is this ongoing awareness that maintains
insight.  As a result, he argues that deficits in the attentional system could result in a
discrepancy between mental events and one’s awareness of them. Keefe (1998)
continues his hypothesis by arguing that patients who cannot distinguish between
internally and externally generated mental events may have particular difficulty
distinguishing observer and observed when trying to gain insight about their symptoms,
behaviors, and circumstances.  Furthermore, he suggests that it is common for such
patients to believe they are not ill, because they cannot take the perspective of the
observer – a necessary step in establishing a context in which to understand their
symptoms. Kinsbourne (1998) also suggests that withdrawal of attention, which could
result from a deviant focus and distribution of attention in psychosis, could lead to
impaired insight.  The withdrawn attention could result in a failure to realize one intended
to act, talk, or think certain thoughts.  Finally, as discussed above, McGlynn and Schacter
(1989) reported anosognosia tends to result from damage confined to the right parietal
lobe, and research has linked the right parietal lobe to the attentional ability to orient to
stimuli (Deutsch et al., 1987).
To date, only a few studies have explored a possible relationship between insight
and attention, but the results have been promising.  Walker and Rossiter (1989) found
psychotic patients with poor insight evidenced poorer attentional performance than their
more insightful counterparts. Lysaker and Bell (1995) conducted a study with
schizophrenic and schizoaffective patients.  Their findings suggested that deficits in
attention and information processing where associated with unawareness of illness.
Finally, Voruganti, Heslegrave, and Awad (1997) found significant correlations between
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insight and several measures of attention (r’s = -.40 to -.52) and random errors on the
WCST (r = -.34).  It is interesting to note that this study found stronger correlations for
attentional tasks and insight than for WCST and insight.  If these findings can be
replicated, it would suggest a productive avenue to pursue in furthering our
understanding of insight.
Social knowledge and insight.  Finally, as mentioned previously, performance on
a test of social knowledge was significantly associated with insight (McEvoy et al.,
1996). McEvoy et al. (1996) found that better performance on the Social Knowledge
Questionnaire (SKQ; Cutting & Murphy, 1988, 1990). McEvoy et al., (1996) suggested
that lack of insight may be a manifestation of a more generalized inability to make
effective judgments about the world.  With regard to the current study, attentional
functioning has been found to be a good predictor of social functioning in patients with
schizophrenia (Addington & Addington, 1998; Freedman et al., 1998; Leih-Mak & Lee,
1997).
In their review of the research findings for information processing and social
functioning, Penn et al. (1997) reported that a correlation between attentional vigilance
(CPT & SPAN) and indices of social functioning were the most consistent findings.  In
another review, Green (1996) also found attentional vigilance was significantly correlated
with social functioning, more specifically social problem solving and skill acquisition.  It
is also important to note that, within this same review, it was reported that verbal memory
and the WCST also predicted aspects of daily living.  Green’s (1996) observations could
lend further support to the findings that social knowledge and insight may be related.
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Purpose
Research into the factors associated with lack of insight has tended to focus on
more general symptom and neurocognitive correlates, and at times produces conflictual
results.  The main factors that have been examined thus far are neurocognitive
functioning (with the majority of focus on possible frontal lobe impairment as measured
by the WCST) and positive symptoms.  Relatively little attention has been focused on
specific symptom correlates of insight, and even less research has been devoted to
investigating an association between attention and insight.  The current study examined
whether there were significant relationships between specific positive symptoms
(including delusions, grandiosity, and disordered thought) neurocognitive impairments,
(with particular focus on attentional impairments), depression, anxiety, and insight in
patients with psychotic disorders.  The overall goal of the current study was to determine
whether or not any of these variables contributed significantly to the prediction of insight.
Finally, an attempt was made to replicate earlier findings which suggested that social
knowledge was significantly associated with insight.  Based on the literature review and
conclusions drawn, the following hypotheses were tested:
Hypothesis 1.  Delusions, grandiosity, and disordered thought would be inversely
correlated with insight, and composites including these symptoms would contribute
significantly to the prediction of insight.  Anxiety and depression would be positively
correlated with insight, and a composite of these symptoms would contribute
significantly to the prediction of insight.
Hypothesis 2.  Neurocognitive deficits would be inversely correlated with insight, and
they would contribute significantly to the prediction of insight.
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Hypothesis 3.  Age would be negatively associated with neuropsychological functioning,
particularly on measures of frontal lobe functioning.
Hypothesis 4.  The combination of neurocognitive factors, delusions, grandiosity,
disordered thought, depression, and anxiety would significantly contribute to the
prediction of insight.
Hypothesis 5.  Performance on the SKQ would be positively correlated with insight.
Hypothesis 6.  The Birchwood Insight Scale, a self-rated scale, would be positively
correlated with the SAI-E, an interviewer rated insight scale.
Because there is little empirical research to support formal hypotheses, the present
study investigated the following research questions:
Question 1.  How did hallucinations correlate with insight?





Forty-four inpatients with a psychotic disorder (i.e., schizophrenia,
schizoaffective disorder, or bipolar disorder with psychotic features) were recruited from
Terrell State Hospital (TSH) in Terrell, Texas.  Of those forty-four, thirty-three were
included in the final sample due to completeness of data and appropriateness of
diagnosis.  TSH is a modern psychiatric facility that serves 22 counties in the
northeastern part of Texas.  A report from TSH for FY98 indicates that the five most
common diagnosis represented there are: Schizoaffective Disorder, Schizophrenia –
Paranoid Type, Psychotic Disorder NOS, Schizophrenia – Undifferentiated Type, and
Bipolar I Disorder.  The average length of stay (LOS) is 78 days, with 72% of patients
having a LOS greater than 30 days.  Eight-one percent of TSH patients are between 19-64
years old.  The gender and racial composition of the total population are as follows: 40%
female; 59% Caucasian, not of Hispanic Origin; 32.5% African-American, not of
Hispanic Origin; and 7% Hispanic.
The presence of psychotic symptoms as well as a schizophrenia spectrum
diagnosis (schizophrenia, schizoaffective disorder, and psychosis NOS) were used as the
primary inclusion criteria.  All participants were tested and found to have at least one
psychotic symptom (i.e. hallucination, delusion, thought disorder, grandiosity) occurring
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during clear consciousness within the two weeks prior to the testing.  Psychotic
symptoms were measured and diagnosis was determined based upon the results of the
Brief Psychiatric Rating Scale (BPRS), chart notes, and past diagnoses. Exclusion criteria
included participants with: Substance-Induced Psychotic Disorder, Psychotic Disorder
Due to a General Medical Condition, Delirium, Dementia, Amnestic and Other Cognitive
Disorders, dual diagnosis of Mental Retardation, Epilepsy, insulin dependent diabetes,
Thyroid Disease, an inability to speak English, or those receiving electroconvulsive
therapy.
Materials
Symptoms.  The Brief Psychiatric Rating Scale (BPRS), Expanded Version (4.0)
(Appendix A) was used to assess the presence of psychopathological symptoms which
were then cross referenced with the participants’ charts.  The BPRS is a semi-structured
interview consisting of 24 items rated on 7-point ordinal scales.  The first fourteen items
are rated based on self-reports and observed behavior; while the remaining items are
rated based on observed behavior and speech (Ventura et al., 1993).
The BPRS has been used extensively in American and European psychiatric
research for almost three decades and has been found to be a reliable instrument (Ventura
et al., 1993). Ventura et al., (1993) studied interrater reliability on the expanded BPRS
for researchers with advanced training degrees and those without.  Interviewers
participating in the study were trained in the guidelines for rating as well as provided
with structured questions to illicit the necessary information from interviewees. They
reported Median ICCs of .81 and .83 respectively. Interrater reliability was measured for
the first 16 items (Overall & Gorham, 1962) on a group of newly admitted schizophrenic
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patients and was found to range from .56 to .87 with 10 of the items falling at .80 or
above.  Suggestions for interview style were provided, but the raters in this study did not
use a structured interview format.  Andersen et al. (1993) also investigated the extent of
practice needed using the BPRS to reach appropriate levels of interrater reliability using a
population of 103 patients with schizophrenia.  They found the lowest mean agreement
for the negative symptoms of the BPRS schizophrenia subscale, while finding a high
degree of agreement for the positive symptoms of the BPRS schizophrenia subscale and
for the symptoms of the depression and mania subscales.
BPRS symptoms subscales have also been shown to measure distinct clinical
dimensions.  Goldman, Tandon, Liberzon, Goodson, and Greden (1991) reported findings
suggesting the positive symptom items of the BPRS and Scale for the Assessment of
Negative Symptoms (SANS; Andreason, 1982) measure distinct clinical dimensions and
that minimal change over time demonstrated that constructs to be stable.  The BPRS
negative symptom subscale has been demonstrated to be unrelated to both the BPRS and
Hamilton Rating Scale for Depression (HRSD; Hamilton, 1960) depression summary
scales (Newcomer, Faustman, Yeh, & Csernansky, 1990).
The BPRS has also been found to be associated with other instruments used to
assess psychopathology.  Newcomer et al. (1990) reported that the BPRS depression
subscale was highly correlated with the HRSD total score (rho = .80). To examine the
potential impact of single symptom factors being defined by different combinations of
BPRS symptoms, Nicholson, Chapman, and Neufeld (1995) pulled several different
BPRS definitions of positive and negative symptoms from research literature and
compared them to each other and to the SANS and the Schedule for the Assessment of
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Positive Symptoms (SAPS; Andreasen, 1984).  They found all the negative symptom
definitions to be highly correlated with each other and the SANS, and all the positive
symptoms definitions to be highly correlated with each other and the SAPS. Czobor,
Bitter, and Volavka (1991) found the SANS and the BPRS to be highly intercorrelated
with the SANS composite score being highly redundant with the anergia factor of the
BPRS.  Another study also found the SANS to be highly correlated with the BPRS
withdrawal-retardation scale, and after a comparison of the interrater reliabilities proved
unfavorable for the SANS, deemed little was gained by using the SANS instead of the
BPRS. Gur et al. (1991) compared the BPRS to the SANS and SAPS and argued the
different scales showed some overlap, but also seemed to measure complementary
aspects of schizophrenia (significant correlations between BPRS factor scores and
subscale scores of the SAPS and SANS, r’s = .31-.69). In a comparison of the BPRS and
the Positive and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & Opler, 1987), Bell,
Milstein, Beam-Goulet, Lysaker, and Cicchetti (1992) found the negative syndromes
were correlated at .82, the positive syndromes correlated at .92, the general scales
correlated at .61, and the scale total scores were correlated .84.
The BPRS has been previously utilized in insight research to provide measures of
psychopathology and specific symptoms (McEvoy et al., 1989a; McEvoy, Applebaum,
Apperson, Geller, & Freter, 1989c; McEvoy et al., 1993; Neumann et al., 1997; Sanz et
al., 1998; Takai et al., 1992; Young et al., 1998).
Insight.  Patient insight was measured using the Schedule for Assessing Insight –
Expanded version (SAI-E; Kemp & David, 1997) (Appendix C).  This measure is a semi-
structured interview where the number of questions answered is determined by the
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answers given to key questions.  The number of items answered on the test can range
from six to nine.  The first six items are rated on a 3-point scale with ratings as follows: 2
= often; 1 = sometimes; 0 = never.  Items 7 and 8 regard specific symptoms, and are
scored on a 5-point scale with 4 = to full awareness and correct attribution and 0 = no
awareness or bizarre/delusional attribution. Item 9 assesses the client’s response to a
hypothetical contradiction of his or her delusions or hallucinatory experiences.  This item
is rated on a 5-point scale with the following ratings: 0 = They’re lying; 1 = I’m still sure
despite what others say; 2 = I’m confused and don’t know what to think; 3 = I wonder
whether something’s wrong with me; and 4 = That’s when I know I’m sick.  The SAI-E
also contains three items regarding treatment compliance that are completed by the
patient’s primary nurse.  The maximum score is 24 points. The SAI-E has been
demonstrated to have high concurrent validity with other measures of insight, namely the
insight question of the Positive and Negative Syndrome Scale for Schizophrenia
(PANSS, Kay et al., 1987) (r = .895), the Insight and Treatment Attitudes Questionnaire
(ITAQ, McEvoy et al., 1989a) (r = .845), and the SAI (r = .977) (Sanz et al., 1998).
Additionally, patient insight will be measured with the Birchwood’s Insight Scale,
a self-report insight scale for psychosis (Birchwood et al., 1994).  The Birchwood’s
Insight Scale consists of eight uncomplicated and direct statements that the patient rates
on a 3-point scale (agree, disagree, unsure) that can be completed quickly by even
seriously disturbed patients.  The test items were designed to assess each of the three
dimensions of insight advocated by David (1990): awareness of illness, ability to relabel
symptoms, and awareness of need for treatment.
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Research on the reliability and validity of the Birchwood’s Insight Scale
(Appendix D) found the test to have a high internal consistency (Cronbach’s alpha = .75)
and high test-retest reliabilities (.90) over a 1-week interval (Birchwood et al., 1994).
Birchwood et al., (1994) also demonstrated the Insight Scale to have adequate construct,
criterion, and concurrent validities and sensitivity to individual difference and change.
Social knowledge.  The Social Knowledge Questionnaire (SKQ, Cutting &
Murphy, 1988, 1990) (Appendix E) is a 9-item multiple choice task designed to measure
how individuals judge or think about events in the real world.  Cutting and Murphy
(1988, 1990) found schizophrenic patients performance on the SKQ was significantly
below that of nonpsychotic psychiatric patients and to inpatients mania or depression
with 65% of schizophrenic patients scoring two standard deviations below the mean of
nonpsychotic patients.
Neurocognition.  Attention was measured with the Continuous Performance Test
– Identical Pairs (CPT-IP) and the Span of Apprehension (SPAN).  The CPT-IP focuses
on visual vigilance and attentional sensitivity and SPAN focuses on selective attention.
The CPT was created by Rosvold, Mirsky, Sarason, Bransome, and Beck (as cited in
Steffy & Oakman, 1997) to measure problems in attention of patients with schizophrenia.
The Identical Pairs version (CPT-IP), one of the most widely used alternative versions of
the CPT, was developed and used extensively as part of the New York High Risk Project
(Cornblatt & Keilp, 1994).  By modifying the definition of the target and by increasing
the complexity of the stimuli, the difficulty of the CPT-IP was significantly increased
from the original CPT. Clients are presented with briefly flashing numbers and shapes on
a computer screen (50 miliseconds) with 150 trials each (client has one second to respond
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to each trial).  The objective is to correctly indicate when a four-digit number or nonsense
shape has been presented on two consecutive trials by releasing the computer mouse key.
Thus, the target is defined by two identical pairs of stimuli and is always changing, which
greatly increases the information processing load (Cornblatt & Keilp, 1994).  Walker (as
cited in Steffy & Oakman, 1997) found the CPT has good sensitivity in differentiating
between RDC-diagnosed patients with either schizophrenia, schizoaffective disorder, or
affective disorders.  In their review of the CPT-IP literature, Cornblatt and Keilp (1994)
found that attentional abnormalities could be found in a variety of populations at risk for
schizophrenia that are not presently symptomatic.
Traditionally, correct responses to stimuli, hits, and incorrect responses to
nontarget stimuli, commission errors, have been the indices most frequently used to
measure performance on CPT tasks (Cornblatt & Keilp, 1994).  Stability across trial
blocks for the CPT-IP has been assessed, and the alpha coefficients ranged from .69 to
.89 for both the hit rate and d’ (a composite score assessing the ability to discriminate the
target from background noise) (Erlenmeyer-Kimling & Cornblatt, 1992). Attentional
abnormalities (as detected by an index derived from the CPT-IP) were found to be stable
over a six to nine year period in adolescents at-risk for schizophrenia (Cornblatt, Winters,
& Erlenmeyer-Kimling, 1989; Winters, Cornblatt, & Erlenmeyer-Kimling, 1991).
In the Span of Apprehension Test, selective attention is measured by asking the
participant to indicate when they have seen the target number.  A series of numbers are
rapidly flashed on various parts of a computer screen with the target number interspersed
throughout.  The client has to ignore the irrelevant numbers and indicate when they have
seen the target.  The ratio of distracting to target numbers becomes increasingly more
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difficult the further through the test the person progresses.  The Span of Apprehension
Test has been found to differentiate patients with schizophrenia from patients with manic-
depression, and from “normal” individuals, penitentiary inmates, and other psychiatric
patients (Asarnow & MacCrimmon, 1981; Neale, 1971; Neale, McIntyre, Fox, &
Cromwell, 1969). Asarnow, Nuechterlein, & Marder (as cited in Steffy & Oakman,
1997) found that adults from low socio-economic statuses with deficits on the Span of
Apprehension measure also had significant elevations on the MMPI Schizophrenia scales
and on other measures of schizotypy.
The Wisconsin Card Sorting Test-Spaulding Version (WCST-S) and the
Controlled Oral Word Association served as assessments of frontal lobe functioning.
Other abilities were also be measured by each of these tests.  These included mental
flexibility and set shifting and verbal fluency respectively.
COGLAB was used to administer the WCST-S.  During this task, the participants
are presented with four stimulus cards – one red triangle, two green stars, three yellow
crosses, and four blue circles - located on a computer screen. The computer will then
present the participant with a trial card that will contain one of four symbols: triangle,
star, cross, or circle in red, green, yellow, or blue.  The participant’s objective is to use
the computer mouse to click on the stimulus card that the trial card should be grouped
with according to a principle that the participant must deduce from the pattern of the
computer’s responses of correct or incorrect to the participant’s placement.  After five
correct placements (consecutive or nonconsecutive), the computer will shift the principle
and indicate this shift only by changing the pattern of correct and incorrect statements
that are flashed on the screen.  Color is the initial basis for sorting, which then shifts to
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form, then to number, returns again to color, and so on.  The test continues until the
participant has completed five runs of five correct placements or has completed a
maximum of 128 trials.  The WCST-S has a greater memory component than the
standard WCST due to the trial card being removed from the screen once it has been
placed and the appropriate feedback has been provided with the WCST-S.
Lezak (1995) reported that there is little doubt that patients with frontal lobe
damage make more perseverative errors than control patients on the WCST. Stuss,
Benson, and Kaplan (1983) compared the performance of patients with schizophrenia
who had undergone frontal leucotomy approximately twenty-five years prior to testing to
the performance of normal control subjects on the WCST.  No difference was found
between the number of categories achieved by the two groups on the first sixty-four
trials, but after all subjects were told about the three possible sorting groups, the controls
significantly improved while the performance of the patients with schizophrenia
deteriorated.  The patients with schizophrenia appeared unable to maintain the principle
for more than three to five sorts. Lezak (1995) reports that WCST has an accuracy range
of 69 to 88% in discriminating patients with brain damage from controls.  Performance
on the WCST has also been found to contribute significantly to the prediction of
improvements in insight (Lysaker & Bell, 1995).  In a multiple regression analysis, they
found the combination of higher scores on a measure of intelligence and sustained
attention and fewer WCST perseverative errors (PE) predicted greater improvements in
insight among patients with diagnoses of schizophrenia and schizoaffective disorder
involved in a work rehabilitation program (total R squared = .34).
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For the Controlled Oral Word Association Test, the participants were asked to say
as many words as they can think of that begin with the given letter of the alphabet (the
letters FAS will be used), excluding proper nouns, numbers, and the same word with a
different suffix.  The participants were provided with a practice trial with the examiner
using the letter “C.”   The practice trial will terminate once the participant has produced
two appropriate words beginning with “C.” Lezak (1995) reported that the Controlled
Oral Word Association is a sensitive indicator of brain dysfunction, and that frontal
lesions, regardless of side, tend to produce lower fluency scores.
Procedure
Patient charts and hospital staff were consulted to ascertain which patients were
diagnosed with a psychotic disorder and did not meet any of the exclusion criteria.  These
patients were then approached in a public area of the unit, told about the study, and asked
if they would be interested in participating.  If they agreed to participate, testing times
were arranged that were convenient for the patients.  Testing typically began immediately
following completion of the informed consent.
All participation was on a voluntary basis (Appendix F).  Informed consent was
obtained from each participant after the procedures involved were explained.  Volunteers
were reimbursed for their participation with five-dollar voucher books that could be used
at the hospital canteen.
Testing was performed in one or two sessions, and the neurocognitive tests were
administered in the following order: CPT-IP, WCST, SPAN, and COWAT.  CPT-IP was
administered first, because the current study was most interested in measuring attention
without fatigue.  Participants were instructed on how to operate the computer before each
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new computer task, and a short practice trial was run with the attention tasks to ensure
they understand the instructions.  After the neurocognitive tasks were administered, the
participants were assessed for symptoms, insight, and social knowledge.  The cognitive
assessments lasted approximately 30-70 minutes, and the interview and self-report





Data was collected from 44 inpatients of which 33 were included in the final
analyses due to completeness of their data and appropriateness of diagnosis.  The sample
consisted of 33 adult inpatients (67% male) diagnosed with a schizophrenia spectrum
disorder (Schizophrenia, Schizoaffective Disorder, and Psychotic Disorder, NOS)
between the ages of 19 and 60 (M = 37.27, SD = 11.22).  All participants were
hospitalized at Terrell State Hospital, a psychiatric hospital facility serving 22 counties in
northeastern Texas.  Table 1 presents a summary of the demographic characteristics for
this sample.
Table 1
Demographic Information for Terrell Patients




Correlations were run to determine how the demographic variables of age,
education, and chlorpromazine equivalents were associated with the symptoms,
neurocognitive scores, insight scores, and SKQ score.  Most of the results were
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nonsignificant (mean r = .02) and fell within the minimal to modest range (absolute r’s =
.004 to .547).  Fairly consistent patterns of nonsignificant correlations were noted
between the insight dimensions and the demographic variables of age and education.
Age tended to be inversely correlated with insight dimensions (mean r = -.06); while,
education showed a positive relationship (mean r = .20).
The most notable correlations were as follows: education was significantly
correlated with WCST perseverative errors (r = -.31, p = .052), WCST categories
completed (r = .43, p = .010), WCST random errors (r = -.45, p = .007), WCST number
correct (r = .41, p = .013), and COWAT total score (r = -.55, p = .001).  As expected,
education was moderately correlated with the WCST and was strongly correlated with
verbal fluency.  Two significant correlations were found between the variable education
and the SKQ (r = .38, p = .020) and the IS awareness subscale (r = .41, p = .012).
Additionally, chlorpromazine equivalence was significantly correlated with the
SAI-E treatment composite (r = .40, p = .010), though to some extent this correlation
maybe artificially inflated due to the composites inclusion of nurses’ reports of
medication compliance.  Another significant correlation was found between
chlorpromazine equivalence and WCST perseverative errors (r = .46, p = .004).
Finally, age was found to have a significant inverse correlation with the negative
symptoms composite (r = -.31, p = .040).
Composite Scores
The internal consistency of each variable composite ranged from fair to excellent.
What follows are the composite names along with the specific BPRS items used in their
formation and the Cronbach’s standardized alpha for that dimension: Anxiety/Depression
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(anxiety, depression, suicide, guilt) = 0.82; Delusions (grandiosity, unusual thought
content) = 0.59; Disorganization (disorientation, conceptual disorganization, mannerisms
and posturing) = .64; and Negative Symptoms (blunted affect, emotional withdrawal,
motor retardation) = .91.
Subscale composites were also created for the Schedule for Assessment of Insight
– Expanded (SAI-E) dimensions of insight. The composites created and their
standardized Cronbach’s alpha are as follows: awareness (SAI-E items 1, 2, 3, 5, 7) = .86,
relabel (SAI-E items 4, 8) = .79, and treatment (SAI-E items 6, A, B, C) = .88. Subscale
composites for the Insight Scale (IS) were created using the formulas provided by the
measures’ creators.  The standardized Cronbach’s alphas for the IS total and subscales are
as follows: IS total = .68, IS awareness (IS items 2, 7) = .51, IS relabel (IS items 1, 8) =
.08, and IS treatment (IS items 3, 4, 5, 6) = .44.
Although composite scores were not utilized with the neurocognitive scores,
correlations were run to assess for redundancy and possible multi-collinearity.
Significant relationships were noted between the SPAN total score and hits-shapes (r =
.51) and hits-numbers (r = .37).  Due to these relationships falling below r = .70, these
scores were not considered redundant and were all included in the stepwise regression
analyses.
Note of caution.  A large number of correlations were run to generate the
following results, and the alpha levels were not corrected.  Therefore, these results should
be interpreted with caution.
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Symptoms and Insight
Hypothesis 1 predicted that delusions, grandiosity (these two symptoms were
combined into one composite entitled delusions), and disordered thought (as measured by
the composite disorganization) would be inversely correlated with insight.  Depression
and anxiety were expected to be positively correlated with insight.  Table 2 shows the
Pearson correlation coefficients between the symptom composites and the dimensions of
insight.
Table 2
Symptom Composites and Insight
                  Insight Dimensions
____________________________________________________________
Symptom SAI-E SAI-E SAI-E SAI-E IS IS IS IS
Composites Total Aware Relabel Tx. Total Aware Relabel Tx.
Anxiety/ .46*   .48*  .38* .30*  .21  .21  .18  .10
Depression
Delusions -.52** -.52** -.44* -.40* -.37* -.23 -.45* -.21
Disorg. -.50* -.41* -.45* -.34* -.24 -.24 -.13 -.20
Negative .29*   .27  .25  .25  .24  .17  .14  .29*
Note.
* denotes p < .05
** denotes p < .001
Eighty-one percent of the correlations between the symptom composites and the SAI-E
dimensions were significant with most of the correlations ranging from moderate to
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strong.  The direction of the significant correlations involving the delusions,
disorganization, and anxiety/depression composites matched the hypothesis.  The
significant associations between symptoms and the IS involved inverse relationships
between the delusions composite and the dimensions of total insight and the ability to
relabel pathological experiences.  Despite failing to show the same pattern of significant
correlations, it is noteworthy that relationships between the IS and symptom composites
were consistently in the predicted direction.
Next stepwise regressions were conducted to determine if the symptoms
composites could predict insight.  Stepwise multiple regressions were conducted with the
SAI-E total and subscores and the IS total and subscores as dependent variables. The
anxiety/depression, delusions, and disorganization composites were the predictor
variables.  Regressions for SAI-E treatment and IS awareness of illness also included the
demographic variables as predictors due to significant correlational relationships.
With respect to total insight as measured by the SAI-E, the delusions and
disorganization composites were significant predictors (F = 11.00, p = .000).  In
predicting awareness of illness, delusions and anxiety/depression achieved significance
(F = 9.21, p = .001).  Disorganization and delusions contributed significantly to the
prediction of the ability to relabel pathological experiences subscale of the SAI-E (F =
7.17, p = .003).  Awareness of the need for treatment was significantly predicted by
chlorpromazine equivalence level and delusions (F = 6.01, p = .007).  See Table 3 for
complete results.
Regarding prediction of self-reported levels of insight on the IS, significant
regression equations were found for all the dimensions except awareness of need for
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treatment.  Delusions significantly predicted both total insight (F = 4.94, p = .03) and the
ability to relabel experiences (F = 7.65, p = .009).  For the dimension of awareness of
illness, education level was as significant predictor (F = 5.64, p = .02).  Results for the
symptom regression equations can be found in Table 3.
Table 3
Regression Analyses of Symptom Prediction of Insight
Criterion Predicator  Beta    Adjusted R2 F p
SAI-E
Total Delusions -.43
Disorganization -.41 .39 11.00 .000
Awareness Delusions -.41
Anxiety/Depression  .35 .34 9.21 .001
Relabel Disorganization -.37
Delusions -.36 .28 7.17 .003
Treatment Chloropromazine
Equivalence  .38
Delusions -.38 .26 6.01 .007
IS
Total Delusions -.37 .11 4.94 .034
Awareness Education  .41 .14 5.64 .025
Relabel Delusions -.45 .17 7.65 .009
Treatment n.s.
_______________________________________________________________________
Neurocognitive Deficits and Insight
Hypothesis two predicted that neurocognitive deficits would be inversely
correlated with and would contribute significantly to the prediction of insight.  The
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Pearson correlation coefficients between neurocognitive performance and the insight
variables are shown in Table 4.
Table 4
Neurocognitive Performance and Insight
Insight Dimensions
_________________________________________________________
Neurocognitive SAI-E SAI-E SAI-E SAI-E IS IS IS IS
Scores Total Aware Relabel TX. Total Aware Relabel TX.
CPT-IP % hits
Numbers .09  .08 -.02  .15 -.07 -.09 -.09  .03
Shapes .31*  .32*  .15  .17  .24  .06  .26  .27
SPAN -.09  .05 -.07 -.32* -.18 -.16  .00 -.27
WCST
Perseverative -.11 -.15 -.14  .16 -.11 -.27 -.05  .10
Errors
Categories -.06 -.11  .13 -.17  .11  .08  .23 -.06
Completed
Random .10  .12 -.08  .29* -.00  .01 -.05  .04
Errors
COWAT -.08 -.09  .03 -.21 -.06 -.05 -.16  .07
Note. * denotes p < .05
As Table 4 illustrates, the majority of the correlations were nonsignificant and fell
within the modest range.   However, CPT-IP shapes (hit rate) showed a consistent
positive relationship with insight.  Significant positive relationships were found between
correct hits on the CPT-IP shapes task and both total level of insight and the awareness
dimension as measured by the SAI-E.
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An unexpected pattern emerged suggesting that as random response styles
increased (r = .29) and selective attention decreased (r = -.32) awareness of the need for
and compliance with treatment increased.
In regression equations including only neurocognitive predictors, none of the
neurocognitive variables accounted for a significant portion of the variance for any of the
dimensions from the two insight measures.
Influence of Age
The next hypothesis predicted that age would be negatively associated with
neuropsychological functioning, particularly measures involving the frontal lobes.  Our
results did not support this hypothesis. The pattern of correlations between age and the
WCST scores were consistent with performance declining with increased age, but age
was not significantly correlated with any of the cognitive variables. All the correlations
fell within the modest range.  Age also failed to significantly contribute to the prediction
of insight, and there was no difference in the predictive value of the neurocognitive
variables whether or not age was included in the regression equation.
Neurocognitive Factors, Symptoms, and Insight
A stepwise multiple regression was conducted to determine if the combination of
neurocognitive factors and the symptom composites would significantly contribute to the
prediction of insight.  The following predictor variables were included in each regression:
anxiety/depression, disorganization, delusions, hits – numbers, hits – shapes, COWAT
total score, SPAN total score.  The insight dimensions for each measure served as
dependent variables. (Regressions were run including all the cognitive, symptom, and
demographic variables, and the results did not change).
39
Results for the SAI-E are presented first.  For the SAI-E total score, greater
delusionality and disorganization, better hit rate for shapes on the CPT-IP and poorer
performance on the SPAN predicted better insight (F = 10.43, p < .000).  For the
Awareness of Mental Illness equation, greater delusionality, better hit rate for shapes, and
increased anxiety/depression predicted a higher level of insight (F = 8.87, p < .000).
Increased disorganization and delusionality predicted a decreased ability to relabel
pathological experiences as part of their illness (F = 6.93, p = .003).  Higher levels of
delusionality also predicted a decreased likelihood of recognizing the need for treatment
(F = 5.79, p = .023).  Table 5 displays the complete regression results.
For the IS total score, greater delusionality predicted less insight (F = 4.78, p =
.037).  Poorer ability to relabel experiences was also associated with increased
delusionality (F = 7.40, p = .011).  The equations for awareness of mental illness and
need for treatment were not significant.  A complete summary of the regression results
for the symptom and neurocognitive predictors can be found in Table 5.
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Table 5
Regression Analyses of Symptom and Neurocognitive Factors Prediction of Insight




Hits – Shapes .49
SPAN Total Score -.34 .55 10.43 <.000
Awareness Delusions -.44
Hits – Shapes .33
Anxiety/Depression .32 .43 8.87 <.000
Relabel Disorganization -.37
Delusions -.36 .28 6.93   .003
Treatment Delusions -.40 .13 5.79   .023
IS
Total Delusions -.37 .11 4.78   .037
Awareness n.s.
Relabel Delusions -.44 .17 7.40   .011
Treatment n.s.
Some of the cognitive, symptom, and insight variables were dichotomized to
permit non-parametric analyses.  None of the non-parametric analyses produced
significant results.
SKQ and Insight
Hypothesis 5 predicted that performance on the SKQ would be positively
correlated with insight.  All correlations between the SKQ and the two insight measures
were positive and ranged from modest to moderate (r’s ranged from .20 to .47).  The
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SKQ was significantly correlated with the following insight dimensions: SAI-E total
insight (.42), SAI-E awareness of illness (.47), SAI-E ability to relabel psychotic
symptoms (.44), IS total insight (.33), and IS awareness of illness (.31).
Post hoc analyses with the SKQ revealed a significant positive relationship with
SPAN total score (r = .34) and significant inverse relationships with delusions (r = -.45)
and disorganization (r = -.35).
Relationship between the SAI-E and the IS
Hypothesis six predicted a positive relationship between the IS and the SAI-E.
Table 6 contains the Pearson Correlation Coefficients between these two measures.
Table 6
IS and the SAI-E
SAI-E Scores
IS Scores SAI-E SAI-E SAI-E SAI-E
Total Aware Relabel Treatment
________________________________________________________________________
IS Total .77** .78** .58** .47*
IS Aware .60** .64** .45* .31
IS Relabel .65** .67** .61** .36*
IS Treatment .56** .55** .32 .46*
Note.
* denotes p < .05
** denotes p < .001
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Table 6 shows that the SAI-E is significantly correlated with the IS on most
dimensions with all but two of the correlations falling in the moderate to strong range.
Consistent positive relationships were found between both measures.
Hallucinations and Insight
The first research question was formulated to assess the possibility that
hallucinations may not correlate with insight in the same direction as other positive
symptoms.  Unlike the other positive symptom composites, no significant correlations
were found between hallucinations and the two insight measures.  Additionally, the
pattern of correlations between hallucinations and the SAI-E and IS was almost entirely
positive (r’s ranged from .25 to -.02), compared to the consistently negative pattern of
correlations found between insight and the delusions and disorganization composites.
Trust and Insight
The second research question was posed to explore whether or not insight is a
dimension of psychotic disorders separate from patients’ level of trust in their doctors.
No significant correlations were found between trust and any of the dimensions of insight
from either of the two insight measures.  Furthermore none of the factors that predicted
insight accounted for a significant portion of the variance in regression equations with




Awareness of mental illness, often referred to as insight, has been associated with
less time spent in the hospital (Van Os et al., 1996), better treatment compliance (Bartko,
Herczeg, & Zador, 1988; David, 1998; David, Buchanan, Reed, & Almeida, 1992;
McEvoy et al., 1989b; Sanz et al., 1998; Van Putten, 1974), more contact with mental
health services (Sanz et al., 1998), and better vocational rehabilitation (Lysaker and Bell,
1995).  For these reasons, gaining a better understanding of the correlates and predictors
of insight are critical to the evaluation and treatment of patients with psychotic disorders.
The current research examined how specific symptom composites and measures of
neurocognitive functioning (particularly attention) were associated with overall insight,
as well as the different dimensions of insight.  A principal finding was that, at least for
acute patients, symptoms tended to have stronger relationships with and were more
regularly predictive of insight than the neurocognitive measures, though attentional
functioning cannot be entirely discounted.  This is fairly consistent with Kemp and
David’s (1996) findings that significant relationships between cognitive functioning and
poor insight were not noted until after acute psychotic symptoms had remitted.
The following discussion of the results is organized into five primary sections: (a)
symptoms and insight; (b) neurocognitive functioning and insight; (c) the combination of
symptoms and neurocognitive functioning in predicting insight; (d) the relationship
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between the SAI-E and the IS; and (e) the SKQ and insight.  Finally, clinical implications
of the results, limitations of the current study, and suggestions for further research are
addressed.
Symptoms and Insight
One of the most consistent findings of the present study, supported by both the
correlational and regression analyses, was that increases in the delusion composite was
associated with decreased levels of insight across the several dimensions and two
measures of insight.  This finding is consistent with previous studies which have reported
a relationship between delusions and insight (Dickerson et al., 1997; Kemp & Lambert,
1995; Neumann, Walker, Weinstein, & Cutshaw, 1996; Sanz et al., 1998; Van Putten,
Crumpton, & Yale, 1976).  This finding seems somewhat straight forward given that the
inherent nature of a delusion is that it consists of a false conviction held contrary to
invalidating facts.  That none of the correlations or beta weights approached .70 argues,
though, that insight and delusions are not redundant aspects of psychotic illness.
As previous research has suggested (David et al., 1992; Nayani & David, 1996;
Neumann et al., 1996), the current study found no significant relationships between
hallucinations and any of the insight dimensions.  It is noteworthy, that the pattern of
correlations between insight and hallucinations was almost entirely positive.  The current
findings of inverse predictive relationships between delusions, disorganization, and
insight, contrasted with a nonsignificant positive relationship between insight and
hallucinations, may help to explain the disparity in the research regarding the relationship
between positive symptoms and insight (Cuesta & Peralta, 1994).  The current results
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suggest it is of greater utility in insight research to explore the role of specific symptoms
rather than large groupings such as “positive symptoms.”
The present findings that anxiety/depression was positively correlated with insight
and predicted increased awareness of illness lends further support to the majority of
previous research findings which have documented a positive relationship between
insight and symptoms of anxiety and depression (Amador et al., 1994; Carroll, Fattah,
Coffey, Owens & Johnstone, 1999; Dickerson, Boronow, Ringel, and Parente, 1997;
Neumann et al., 1996; Sanz et al., 1996; Smith et al., 1999).
As discussed in the introduction, David (1990) suggested that insight into
psychosis may in fact be a tragic and painful struggle against the psychotic disturbance.
Perhaps the capacity for insight develops as patients first become aware, to a greater or
lesser degree, of their abnormal perceptual experiences such as attentional abnormalities
and hallucinations.  With this awareness comes a need to construct a personally
meaningful interpretation of such experiences.  Delusions may develop as a way to
protect oneself against the anxiety and depression that can arise with the alternative
interpretation that one may have a highly stigmatized mental illness.  If this hypothesis is
correct, then certain factors can be highlighted to help mental health employees attempts
to raise their patients level of insight.  Interventions to increase insight should focus on
helping patients learn to identify the first signs of unusual perceptual experience and to
make more accurate attributions of such experiences.  These interventions would benefit
from recognizing increases in anxiety and depression.  As such, treatment should include
a component designed to reduce shame and raise and maintain self-esteem within a frame
of acknowledgment and understanding of their mental illness.
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Neurocognitive Functioning and Insight
Previous research has suggested a relationship might exist between attention and
insight (Lysaker & Bell, 1995; Voruganti, Heslegrave, and Awad, 1997; Walker &
Rossiter, 1989).  The present study’s findings of significant positive correlations between
hit rate for shapes on the CPT-IP and the dimensions of total insight and awareness of
illness are consistent with these other studies.  As previously discussed, the CPT-IP is a
measure of processing ability and sustained attention.
Research has found that the CPT-IP shapes subtest is associated with relatively
more right hemisphere activity than left, in non-impaired individuals (Cornblatt & Keilp,
1994). In patients with schizophrenia, it has been noted that there appears to be a failure
of appropriate lateralization, which may be related to metabolic dysfunction in the basal
ganglia.  The current findings suggest that better insight is associated with a greater
capacity for appropriate lateralization and functioning of the right hemisphere. Thus, the
current study implicates involvement of right hemisphere functioning with better insight,
which is an extension of the literature that has primarily addressed a relationship between
frontal lobes (as measured by the WCST) and insight (Lysaker et al., 1998; Lysaker &
Bell, 1994; Lysaker & Bell, 1998; McEvoy et al., 1996; Voruganti et al., 1997; Young et
al., 1993).  The current research findings fit nicely with the literature linking anosognosia
most typically with lesions of the right parietal lobe (McGlynn & Schacter, 1989).
An unexpected finding emerged from the current data suggesting that increased
random errors on the WCST and poorer overall performance on the SPAN (tasks
measuring selective attention in the presence of concurrent distracters) were associated
with increased awareness of the need for treatment and treatment compliance.  These
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findings are contradictory to those of Voruganti, Heslegrave, and Awad (1997) whom
reported an inverse relationship between random errors and insight and positive
relationships between several measures of attention and insight. It should be noted,
however, that the Voruganti et al. (1997) findings were based upon relationships with a
single insight item from the Positive and Negative Symptoms Scale rather than a more
comprehensive measure. The current results may be due to chance, or they could suggest
a curious aspect of treatment compliance in acute patients involuntarily committed to a
mental health facility.  For such individuals, greater treatment compliance may be related
more to a decreased ability to consistently protest treatment than to an awareness of the
need to treat a psychotic illness.
Interestingly, the current research did not find a relationship between impaired
insight and poor performance on the WCST, which has frequently been cited in the
literature (Lysaker et al., 1998; Lysaker & Bell, 1994, 1998; McEvoy et al., 1996;
Voruganti et al., 1997; Young et al., 1993).  However, other studies have also failed to
find an association between the WCST and insight (Cuesta & Peralta, 1994, 1995;
McEvoy et al., 1993; Sanz et al., 1998).  Thus, continued research on the relationship
between executive measures and insight is warranted.
The Combination of Symptoms and Neurocognitive Functioning in Predicting Insight
As with the results of the symptom composite regressions, the findings of the
more inclusive stepwise regression analyses revealed delusions to be the most consistent
predictor of insight and its dimensions.
An interesting change occurred in the results from the smaller specific regressions
to the more inclusive ones.  Though the predictive symptom composites factored in the
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same order and remained consistent across analyses, attentional performance played a
significant predictive role in the combined regressions.  These results occurred despite all
the neurocognitive specific regressions being nonsignificant.  Taking into account the
significant zero-order correlations between hits-shapes and total insight and the
awareness subscale, it is possible that the modest relationship demonstrated more
predictive power once a portion of the variance was accounted for by one or more of the
symptom composites.  These current findings extend the literature by demonstrating that
better attentional functioning can contribute significantly to the prediction of insight.
Noteworthy was that increases in the SPAN total predicted a decrease in total
insight (SAI-E).  A review of the correlational data indicated a nonsignificant and
extremely minimal (.09) relationship between these variables.  This regression result may
be attributable to chance.  However, it is also possible that the previous variables entered
into the regression equation may be moderating the relationship between SPAN total and
insight.
The Relationship Between the SAI-E and the IS
 A rather unique feature of the current research was the inclusion of both
subjective (self-report) and more objective (interview) assessments of insight.  The
correlational results suggest good concurrent validity between the SAI-E and the IS
across total and subscale scores.  Additionally, the pattern of correlations between the
insight measures and the neurocognitive and symptom variables were similar, though
fewer statistically significant relationships were noted between the IS and the
neurocognitive and symptom variables.  While several factors contributed to the
49
prediction of insight on the SAI-E, only delusions and education level served as
significant predictors for the IS.
Several explanations can be offered for the slightly different research results
between the SAI-E and the IS, despite their strong relationships with one another.  First,
self-report measures create additional variance through the influence of education and
reading level as well and their ability to be influenced by the emotional state of the
individual (Hart & Hare, 1997).  On the other hand, interview formats can help reduce
variance through rater monitoring and appropriate probing, as long as raters have been
adequately trained and establish acceptable levels of interrater reliability.  Potentially
greater nuisance variance in the IS data may have made it more difficult to achieve
significance, particularly with the current sample size.
A second potential explanation for the different results stems from the different
nature of the data collected: self-perceptions versus more objective, interviewer ratings.
The only predictor of IS scores was delusionality.  Perhaps when is comes to self-
perceived levels of insight, neurocognitive factors and other symptoms are far less
important than whether the individual presents with delusional thoughts.
The level of concurrent validity found between the two insight measures has
clinical utility.  The present results suggest that the IS can, in some cases, be substituted
as a quick and acceptable self-report of insight instead of using a longer interview format.
For example the IS may be acceptable and more desirable for use in treatment facilities or
in research were a screen of insight is suitable.
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SKQ and Insight
Results from the current study replicated the McEvoy et al., (1996) findings of a
significant relationship between insight and common sense, as measured by the SKQ.
Our findings extended the previous research by demonstrating relationships between
insight and the SKQ using different measures of insight (SAI-E vs. ITAQ) and a different
method of insight assessment (self-report).  Additionally, the current research explored
and found significant relationships between common sense and specific dimensions of
insight as well as with total level of insight.
The present findings of a positive relationship between the SPAN total score and
the SKQ lends support to previous research findings suggesting attentional functioning
serves as a good predictor of social judgment and functioning in patients with
schizophrenia (Addington & Addington, 1998; Freedman, Rock, Roberts, Cornblatt, &
Erlenmeyer-Kimling, 1998; Leih-Mak & Lee, 1997).  Such findings are of clinical utility,
because they lend further support to treatment programs that include components which
teach patients how to attend to important cues and disregard irrelevant cues in social
interactions.  One such program presently in use primarily in Europe is Integrated
Psychological Therapy (IPT; Brenner et al., 1994).
Clinical Implications
The findings of the current research have implications for clinical treatment; a
summary of which follows.  First, it is likely that treatment programs designed to raise
the level of insight in patients would be best suited to individuals who are stabilized.
Second, clinicians undertaking such a program should be aware of the risks of
increased anxiety and/or depression in patients’ whose level of insight improves.  It
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would appear beneficial for such programs to include steps to decrease the likelihood of
concurrent anxiety and/or depression through activities designed to increase self-esteem
and teach relaxation techniques.  Additionally, it may prove useful to consult with
members throughout an insight treatment program, so that psychiatrists and other mental
health workers can be alerted to the possibility of a temporary increase in anxiety and
depression to facilitate early detection and appropriate treatment.
Third, given the current findings implicating right hemisphere functioning in
insight, it is possible neurocognitive rehabilitation may also help improve levels of
insight.  Thus, treatment programs may find it of utility to intersperse activities designed
to improve attentional functioning, particularly if these activities also included social
judgment components.
Limitations
Although the current results are provocative, they must be viewed as tentative,
given the following limitations of the study.  First this study is based on a small sample
size which did not allow for sufficient power in the regression analyses.  Still, it should
be noted that the majority of our findings were consistent with or extended the previous
literature in the hypothesized directions.  Second, the same rater conducted the symptom
and insight interviews, and this may have inflated the relationships between the symptom
ratings and the SAI-E.  However, it is notable that the self-report of insight was also
significantly correlated with symptoms. Third, the study population consisted of a higher
percentage of minorities than found in the general population.  Additionally, the
percentage of female participants is also greater than percentages typically reported for
the schizophrenia spectrum disorders.  These differences may effect the generalizability
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of the current findings.  Fourth, the lack of an even distribution across the age range in
this sample prevented us from more fully evaluating any potential effects age might have
in moderating the relationship between neurocognitive functioning (particularly on
frontal lobe measures) and insight.
Future Directions
The current study suggests several new directions for research on insight.
Research should include additional samples beyond acute populations recently committed
to state mental institutions.  Included in this recommendation are inpatients ready for
discharge to the community and stabilized outpatients.
Furthermore, longitudinal studies exploring changes in symptom levels,
neurocognitive functioning, and insight levels over time would be useful in explaining
the role of insight in psychotic disorders.  It would prove particularly valuable for future
research to include data collected during multiple acute, recovery, and stabilized phases.
Such research may help shed further light on the question of insight as an independent
construct.  Additionally, it may further elucidate whether insight fluctuations within the
individual are the sole product of illness status or additional factors.
The relationship between insight and social knowledge or common sense also
deserves closer consideration.  The current study found SKQ performance was related to
total insight as well as several insight dimensions and attentional performance.  A more




BRIEF PSYCHIATRIC RATING SCALE
NA = Not assessed   1 = Not present   2 = Very mild   3 = Mild   4 = Moderate  5 =
Moderately Severe   6 = Severe   7 = Extremely Severe
  1. Somatic concern NA   1   2   3   4   5   6   7
  2. Anxiety NA   1   2   3   4   5   6   7
  3. Depression NA   1   2   3   4   5   6   7
  4. Guilt NA   1   2   3   4   5   6   7
  5. Hostility NA   1   2   3   4   5   6   7
  6. Suspiciousness NA   1   2   3   4   5   6   7
  7. Unusual thought content NA   1   2   3   4   5   6   7
  8. Grandiosity NA   1   2   3   4   5   6   7
  9.  Hallucinations NA   1   2   3   4   5   6   7
10. Disorientation NA   1   2   3   4   5   6   7
11. Conceptual disorganization NA   1   2   3   4   5   6   7
12. Excitement NA   1   2   3   4   5   6   7
13. Motor retardation NA   1   2   3   4   5   6   7
14. Blunted affect NA   1   2   3   4   5   6   7
15. Tension NA   1   2   3   4   5   6   7
16. Mannerisms and posturing NA   1   2   3   4   5   6   7
17. Uncooperativeness NA   1   2   3   4   5   6   7
18. Emotional withdrawal NA   1   2   3   4   5   6   7
19. Suicidality NA   1   2   3   4   5   6   7
20. Self-neglect NA   1   2   3   4   5   6   7
21. Bizarre behavior NA   1   2   3   4   5   6   7
22. Elated mood NA   1   2   3   4   5   6   7
23. Motor hyperactivity NA   1   2   3   4   5   6   7
24. Distractibility NA   1   2   3   4   5   6   7
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Appendix B
Positive and Negative Affect Scales (PANAS)
This scale consists of a number of words that describe different feelings and emotions.
Read each item and then mark the appropriate answer in the space next to that word.
Indicate to what extent you have felt this way during the past week.  Use the following
scale to record your answers.
1 (very slightly or not at all)
2 (a little)
3 (moderately)
4 (quite a bit)
5 (extremely)
____ interested ____ irritable
____ distressed ____ alert
____ excited ____ ashamed
____ upset ____ inspired
____ strong ____ nervous
____ guilty ____ determined
____ scared ____ attentive
____ hostile ____ jittery
____ enthusiastic ____ active
____ proud ____ afraid
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Appendix C
Schedule for the Assessment of Insight (SAI-E)
1.  "Do you think you have been experiencing any emotional or psychological changes or
difficulties?"
Often (thought present most of the day, most days) ..................................................... = 2
Sometimes (thought present occasionally) ................................................................... = 1
Never (ask why doctors/others think so) ...................................................................... = 0
If brief write verbatim reply, otherwise summarize response.  Please add explanatory
comments if appropriate.
2.  "Do you think this means there is something wrong with you?" (For example, a
nervous condition).  If previous answer was "never" or "no" ask; "If the doctor(s) and/or
others think you have been experiencing emotional or psychological changes or
difficulties do you think there must be something wrong with you even though you don't
feel it yourself?"
Often (thought present most of the day, most days) ..................................................... = 2
Sometimes (thought present occasionally) ................................................................... = 1
Never (ask why doctors/others think so) ...................................................................... = 0
If brief write verbatim reply, otherwise summarize response.  Please add explanatory
comments if appropriate.
3.  "Do you think your condition amounts to a mental illness or mental disorder?"
Often (thought present most of the day, most days) ..................................................... = 2
Sometimes (thought present occasionally) ................................................................... = 1
Never (ask why doctors/others think so) ...................................................................... = 0
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If brief write verbatim reply, otherwise summarize response.  Please add explanatory
comments if appropriate.
If positive score on previous two items, proceed to 4, otherwise go to item 6.
4.  "How do you explain your condition/disorder/illness?"
Reasonable account given based on plausible mechanisms
(appropriate given social, cultural and educational background,
e.g. excess stress, chemical imbalance, family history, etc.)......................................... = 2
Confused account, or overheard explanation without adequate
understanding or "don't know"..................................................................................... = 1
Delusional or bizarre explanation ................................................................................ = 0
If brief write verbatim reply, otherwise summarize response.  Please add explanatory
comments if appropriate.
If positive score on items 1,2, and 3, proceed to 5, otherwise go to item 6.
5.  "Has your nervous/emotional/psychological/mental/psychiatric condition (use
patient’s term) led to adverse consequences or problems in your life? (For example,
conflict with others, neglect, financial or accommodation difficulties, irrational,
impulsive or dangerous behavior).
Yes (with example) ..................................................................................................... = 2
Unsure (cannot give example or contradicts self) ......................................................... = 1
No ............................................................................................................................... = 0
If brief write verbatim reply, otherwise summarize response.  Please add explanatory
comments if appropriate.
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6.  "Do you think your .... condition (use patient's term) or the problems resulting from it
warrants (needs) treatment?"
Yes (with example) ..................................................................................................... = 2
Unsure (cannot give example or contradicts self) ......................................................... = 1
No ............................................................................................................................... = 0
If brief write verbatim reply, otherwise summarize response.  Please add explanatory
comments if appropriate.
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7.  Pick the most prominent symptoms up to  a maximum of 4.  Then rate awareness of
each symptom out of 4 as below.  (Interviewer to assess which symptoms to rate from
previous interviews e.g. highest scoring on BPRS and/or from patient's current
presentation).
Examples:
"Do you think that the belief ... is not really/ happening (could you be imagining things)?
"Do you think the 'voices' you hear are actually real people talking, or is it something
arising from you own mind?"
"Have you been able to think clearly, or do your thoughts seem mixed up/ confused?  Is
your speech jumbled?"
"Would you say you have been more agitated/ overactive/ speeded up/ withdrawn than
usual?"
"Are you aware of any problem with attention/ concentration/ memory?"
"Have you a problem with doing what you intend/ getting going/ finishing tasks/
motivation?"
Symptom 1 - type: rating:
Symptom 2 - type: rating:
Symptom 3 - type: rating:
Symptom 4 - type: rating:
Definitely (full awareness) = 4
Probably (moderate awareness) = 3
Unsure (sometimes yes, sometimes no) = 2
Possibly (slight) = 1
Absolutely not (no awareness) = 0 Mean rating:
If brief write verbatim replies, otherwise summarize responses.  Please add explanatory
comments if appropriate.  (Use other side of page if additional space is needed).
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8.  For each symptom rated above (up to a maximum of 4), ask patient ... "How do you
explain ... (false beliefs, hearing voices, thoughts muddled, lack of drive, etc.)?"
Symptom 1: Symptom 2:
Symptom 3: Symptom 4:
Part of my illness: = 4
Due to nervous condition = 3
Reaction to stress/ fatigue = 2
Unsure, maybe one of the above = 1
Can't say, or delusional/ bizarre explanation = 0 Mean rating:
If brief write verbatim replies, otherwise summarize responses.  Please add explanatory
comments if appropriate.
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9.  "How do you feel when people do not believe you? (when you talk about ... delusions
or hallucinations)."
That's when I know I'm sick = 4
I wonder whether something's wrong with me = 3
I'm confused and I don't know what to think = 2
I'm still sure despite what others say = 1
They're lying = 0
If brief write verbatim replies, otherwise summarize responses.  Please add explanatory
comments if appropriate.
Please turn to the last page after the interview and fill in grid as appropriate.
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Compliance to treatment/ therapy/ medication - patient's primary nurse to rate
following three items (A-C).
A. How does patient accept treatment (includes passive acceptance)?
Often (may rarely question need for treatment)............................................................ = 2
Sometimes (may occasionally question need for treatment) ......................................... = 1
Never (ask why) .......................................................................................................... = 0
Please add explanatory comments if appropriate.
B. Does patient ask for treatment unprompted?
Often (excludes inappropriate request for medication, etc.) ......................................... = 2
Sometimes (rate here if forgetfulness/ disorganization leads
to occasional requests only) ......................................................................................... = 1
Never (ask why doctors/ others think so) ..................................................................... = 0
Please add explanatory comments if appropriate.
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C.  Summary of compliance to treatment/ therapy/ medication.
Complete refusal ......................................................................................................... = 1
Partial refusal (e.g. refusing depot drugs or accepting only the minimum dose) ........... = 2
Reluctant acceptance (accepting only because treatment is compulsory or .................. = 3
questioning the need for treatment often e.g. every two days)
Occasional reluctance about treatment (questioning the need for treatment .................. = 4
once a week)
Passive acceptance ...................................................................................................... = 5
Moderate participation (some knowledge of and interest in treatment and no............... = 6
prompting needed to take the drugs)
Active participation (ready acceptance, and taking some responsibility for ................. = 7
treatment)
Please add explanatory comments if appropriate.

























Please read the following statements carefully and then check the black which best
applies to you:
Agree Disagree Unsure
1.  Some of my symptoms were made by my mind _____ _____ _____
2.  I have always been mentally well _____ _____ _____
3.  I did not need medication.
_____ _____ _____
4.  My stay in the hospital was necessary. _____ _____ _____
5.  The doctor was right in prescribing medication
for me. _____ _____ _____
6.  I did not need to be seen by a doctor or
psychiatrist.
_____ _____ _____
7.  If someone said I would have a nervous or
mental illness, they would be right. _____ _____ _____
8.  None of the unusual things I experienced





Please circle the answer that best answers the question.
1.  Why do you think the divorce rate is so high?
a. The birth rate is high.
b. There are too many police around.
c. The cost of living is high.
d. Divorce laws now make divorce easy.
2.  What do you think would be most likely to happen if suddenly there were no more
police?
a. More suicides.
b. More people on the streets.
c. More burglaries.
d. Fewer cops and robbers films on the TV.
3.  What do you think would be the most sensible thing to say if you came across two
strangers having a fight in the street?
a. I suppose you think you're clever.
b. The police are coming.
c. Stop it.  You'll lose your jobs.
d. Stop it.  You'll upset your mothers.
4.  Why do you think that some men gamble excessively?
a. They need continual excitement.
b. They had overprotective mothers.
c. They enjoy losing money.
d. They are of low intelligence.
5.  How would you tell a friend politely that they had stayed too long at your house?
a. You'd better go.  I'm fed up with you staying too long.
b. Haven't you got anything better to do?
c. Excuse me.  I've got an appointment with a friend.
d. There's no more coffee left.
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6.  What helpful thing could you say to a friend who was continually being harassed by a
neighbor?
a. Don't worry.  I've heard she is unpleasant to everybody.
b. Why don't you throw some trash over into her yard?
c. You probably deserve it.  You're a noisy person.
d. There's nothing you can do.  You'll have to move.
7.  Why do you think identical twins are emotionally alike?
a. They're brought up on the same food.
b. They've inherited the same characteristics.
c. They probably get the same presents at Christmas.
d. No one will play with them because they are so strange.
8.  What sort of people do you think make the best lawyers?
a. People who get angry with the way the country is run.
b. People who like talking a lot.
c. People who don't drink or smoke.
d. People with an eye for detail.
9.  If you won the lottery, how would you best guarantee a large income for the rest of
your life?
a. Buy shares in an Australian gold mine.
b. Bet it on the favorite in the Kentucky Derby.
c. Give it to your neighbor to look after.
d. Place it with an investment company in the city.
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